Current situation and reflection on the development of new traditional Chinese medicine
Based on data released by the National Drug Administration from 2021 to 2022.The number of new traditional Chinese medicine approved for marketing was relatively small.This article reviewed the research and development of new traditional Chinese medicine which play a crucial role in the inheritance of new traditional Chinese medicine,the assistance of clinical treatment with traditional Chinese medicine,and the survival of pharmaceutical enterprises.Therefore,research is conducted on the issues,methods,and policies of new traditional Chinese medicine drug to provide ideas.The development of new drugs is expected to adhere to traditional Chinese medicine theory,guide by clinical value,emphasize human experience,and control the quality in the entire process.The clinical advantages of traditional Chinese medicine were highlighted,to keep pace with the times,innovate new mechanisms for cultivating traditional Chinese medicine talents,and promote faster development of new Chinese medicine.
new traditional Chinese medicineinnovationclinicpolicy analysis
NETL
NSTL
万方数据
